Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Plasmalyte 148® and Saline for Fluid Resuscitation and Intravenous Fluid Therapy in Critically Ill Adults

NCT02721654 is registered in ClinicalTrials.gov with The George Institute as lead sponsor.

NCT NCT02721654
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02721654 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Plasmalyte 148® and Saline for Fluid Resuscitation and Intravenous Fluid Therapy in Critically Ill Adults
Lead sponsor
The George Institute
Phase
Phase 4
Overall status
Completed
Start date
September 1, 2017
Completion date
June 30, 2021
Enrollment
5,037 (actual)
Sites
51

Conditions

As the registry lists them; a condition with its own page is linked.

hypovolemia